Brazil may be a popular topic in international investing, but it's
actually not all that easy to invest in some of the best Brazilian
growth stories. Such is the case with Natura Cosmeticos (NUACF.PK).
Natura is a true Brazilian success story and a fantastic play on the
Brazilian consumer, but the U.S. ADR has virtually no liquidity and
Brazil is an "institutions only" market for foreign investors. That
said, there are readers who can buy these shares and even if you cannot
own Natura today, it's a stock well worth following if you want to know
more about what's going on in Brazil beyond the government-reported
statistics.
Read more here:
Expensive And Hard To Own, Natura Cosmeticos Is Still A Great Brazil Play
Showing posts with label Avon Products. Show all posts
Showing posts with label Avon Products. Show all posts
Saturday, March 16, 2013
Monday, June 4, 2012
Investopedia: Control May Be Herbalife's Real Long-Term Problem
Herbalife (NYSE:HLF)
has gotten knocked around hard lately, as well-known investor David
Einhorn has apparently taken some interest in the company and asked some
fairly pointed questions. Although I don't agree with those who have
interpreted his questions as implying that there is any sort of pyramid scheme
at work, that doesn't mean that there aren't inherent issues with the
Herbalife model. While there is likely to be sustained ongoing demand
for the sort of supplements that Herbalife sells, I wonder whether
Herbalife's model takes too much of the company's growth potential out
of its own hands.
Please read more here:
http://stocks.investopedia. com/stock-analysis/2012/ Control-May-Be-Herbalifes- Real-Long-Term-Problem-HLF- MED-VSI-ARNA-VVUS-AVP0604.aspx
Please read more here:
http://stocks.investopedia.
Labels:
Arena Pharmaceuticals,
Avon Products,
Herbalife,
Medifast,
Vitamin Shoppe,
Vivus
Wednesday, November 2, 2011
Seeking Alpha: Little Wrong With Herbalife Other Than Its Valuation
The devil's bargain between Wall Street and growth stocks goes a little something like this: “You give us exactly the growth we expect or more (but never less!) and we'll support extreme valuations that your cash flow probably can't support”. There's also an “or else” attached – if a company disappoints even slightly, there's an outsized price to pay.
Honestly, that's about the only context in which Herbalife (NYSE: HLF) is really disappointing anyone, and perhaps shareholders can count themselves lucky that the stock isn't down even worse against a backdrop of a pretty ugly tape.
To read the full piece at Seeking Alpha, click here:
Little Wrong With Herbalife Other Than Its Valuation
Honestly, that's about the only context in which Herbalife (NYSE: HLF) is really disappointing anyone, and perhaps shareholders can count themselves lucky that the stock isn't down even worse against a backdrop of a pretty ugly tape.
More Growth In Q3
Herbalife's growth is almost hard to believe. Apparently there really is gold in guarana, protein shakes, and the other assorted supplements and “solutions” that the company offers through its army of over 2 million independent sellers.To read the full piece at Seeking Alpha, click here:
Little Wrong With Herbalife Other Than Its Valuation
Labels:
Amazon,
Avon Products,
GNC,
Herbalife,
Nu Skin Enterprises,
USANA,
Vitamin Shoppe
Wednesday, June 8, 2011
Investopedia: Waiting For A Clearance Sale On Ulta
As investors in retailers like Talbots (NYSE:TLB) or American Eagle (NYSE:AEO) can easily attest, this is not the easiest environment for retail. Oh true, conditions are better now than a year or two ago, but retailers really need to offer something distinctive in terms of product selection, pricing or shopping experience to draw in the crowds.
To that end, Ulta (Nasdaq:ULTA) seems to have hit on an attractive and differentiated concept - a beauty and personal care superstore format that is competitive on pricing while offering a wide selection and pleasant environment. Like lululemon (Nasdaq:LULU) and its own differentiated products and branding, Ulta is carving out an impressive growth trajectory while many of its rivals are struggling to hold on to what they have.
Keeping up the Momentum in Q1
Ulta's fiscal first quarter showed no slowdown in the company's momentum. Sales were up almost 21% on a reported basis, with same-store sales up more than 11%. There is a decided lack of direct comps to Ulta (one of the positives in the company's thesis), but anecdotal from the likes of Macy's (NYSE:M), Nordstrom (NYSE:JWN) and Kohl's (NYSE:KSS) would suggest that Ulta's performance is quite a bit stronger than the average department store cosmetics counter.
To read the full piece, please follow the link:
http://stocks.investopedia.
Labels:
Avon Products,
CVS,
Kohl's,
lululemon,
Macy's,
Nordstrom,
Sally's Beauty,
target,
Ulta Salons,
Walgreens
Subscribe to:
Posts (Atom)